SPAC Overview
$60M
IPO Size
$58.7M
Trust Amount
Failed
Current Status
2007
IPO Year
Timeline Progress
About
Apex Bioventures Acquisition Corporation is a blank-check company formed to acquire one or more operating businesses in the healthcare industry through a business combination. It had no specific target under consideration at the time of filing.
Investment Focus
Healthcare
The terms and the filing trail behind APEX BIOVENTURES ACQUISITION CORP
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Leadership
Darrell J. Elliott
Chairman of the Board of Directors, Chief Executive Officer, Chief Financial Officer, Director, Executive Vice President
K Michael Forrest
Chairman of the Board of Directors, Chief Executive Officer, Chief Operating Officer, Director, President
Gary E. Frashier
Chief Financial Officer, Director, Executive Vice President, Secretary
Robert J. Easton
Chief Operating Officer, Director, President
John J. Chandler
Director, Secretary
Anthony J. Sinskey
Director
Donald B. Rix
Director
Nancy T. Chang
Director
Robert Van Nostrand
Director
Giva H. Frashier
Extended Team Information
The management team includes experienced healthcare and life-sciences executives and investors with backgrounds in biotechnology, pharmaceuticals, healthcare consulting, venture capital, and company management.
Key Information
IPO Date
June 8, 2007
State of Incorporation
DE
SIC
6770
Failed Date
June 2, 2009
SPAC Ticker
PEX